Samuel Z. Goldhaber, MD, offers insight into how healthcare providers can protect medically ill patients from developing VTE and stroke.
From the 19th Annual Antithrombotic Therapy Symposium, Wayne State University
Related Articles
November 15, 2018
Clot Chronicles: An Update on Baby Aspirin
Dr. Sam Goldhaber offers insight into recent trials that bring into question what many believe about baby aspirin. Hello. This…
November 7, 2018
A DOAC Deep Dive: Edoxaban
For the past several decades, warfarin has been the go-to anticoagulant (blood thinner) for doctors, but new treatments have recently…
November 7, 2018
The MARINER Trial: Know The Risk of Blood Clots in the Hospital
Did you know that in the United States alone 400,000 blood clot events occur in patients recently discharged from the…